These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22043839)

  • 1. Managing the combination of nonalcoholic fatty liver disease and metabolic syndrome.
    Moscatiello S; Di Luzio R; Sasdelli AS; Marchesini G
    Expert Opin Pharmacother; 2011 Dec; 12(17):2657-72. PubMed ID: 22043839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome.
    Boppidi H; Daram SR
    Postgrad Med; 2008 Jul; 120(2):E01-7. PubMed ID: 18654060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.
    Tilg H; Moschen A
    Minerva Gastroenterol Dietol; 2010 Jun; 56(2):159-67. PubMed ID: 20485253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic syndrome and nonalcoholic fatty liver disease.
    Collantes RS; Ong JP; Younossi ZM
    Panminerva Med; 2006 Mar; 48(1):41-8. PubMed ID: 16633331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nonalcoholic fatty liver disease and the metabolic syndrome: clinical implications and treatment.
    Rahimi RS; Landaverde C
    Nutr Clin Pract; 2013 Feb; 28(1):40-51. PubMed ID: 23286927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expert opinion on current therapies for nonalcoholic fatty liver disease.
    Della Corte C; Alisi A; Iorio R; Alterio A; Nobili V
    Expert Opin Pharmacother; 2011 Aug; 12(12):1901-11. PubMed ID: 21639814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weight loss as a treatment for nonalcoholic fatty liver disease.
    Clark JM
    J Clin Gastroenterol; 2006 Mar; 40 Suppl 1():S39-43. PubMed ID: 16540766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-alcoholic fatty liver disease from pathogenesis to management: an update.
    Musso G; Gambino R; Cassader M
    Obes Rev; 2010 Jun; 11(6):430-45. PubMed ID: 19845871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonalcoholic fatty liver disease and the metabolic syndrome.
    Marchesini G; Babini M
    Minerva Cardioangiol; 2006 Apr; 54(2):229-39. PubMed ID: 16778754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: the treatment of fatty liver disease associated with the metabolic syndrome.
    Marchesini G; Natale S; Manini R; Agostini F
    Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():37-9. PubMed ID: 16225470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-alcoholic fatty liver disease in children now: lifestyle changes and pharmacologic treatments.
    Alisi A; Nobili V
    Nutrition; 2012 Jul; 28(7-8):722-6. PubMed ID: 22464551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonalcoholic fatty liver disease: the hepatic metabolic syndrome.
    Page J
    J Am Acad Nurse Pract; 2012 Jun; 24(6):345-51. PubMed ID: 22672485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive-behavioral treatment of nonalcoholic Fatty liver disease: a propensity score-adjusted observational study.
    Moscatiello S; Di Luzio R; Bugianesi E; Suppini A; Hickman IJ; Di Domizio S; Dalle Grave R; Marchesini G
    Obesity (Silver Spring); 2011 Apr; 19(4):763-70. PubMed ID: 20966900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diets and nonalcoholic fatty liver disease: the good and the bad.
    Asrih M; Jornayvaz FR
    Clin Nutr; 2014 Apr; 33(2):186-90. PubMed ID: 24262589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of non-alcoholic fatty liver disease on accelerated metabolic complications.
    Fan JG
    J Dig Dis; 2008 May; 9(2):63-7. PubMed ID: 18419637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of weight loss on nonalcoholic fatty liver disease.
    Patel AA; Torres DM; Harrison SA
    J Clin Gastroenterol; 2009; 43(10):970-4. PubMed ID: 19727004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease: from clinical recognition to treatment.
    Sevastianos VA; Hadziyannis SJ
    Expert Rev Gastroenterol Hepatol; 2008 Feb; 2(1):59-79. PubMed ID: 19072371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment.
    Milić S; Stimac D
    Dig Dis; 2012; 30(2):158-62. PubMed ID: 22722431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NAFLD in the absence of metabolic syndrome: different epidemiology, pathogenetic mechanisms, risk factors for disease progression?
    Yilmaz Y
    Semin Liver Dis; 2012 Feb; 32(1):14-21. PubMed ID: 22418884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention and treatment of nonalcoholic fatty liver disease.
    Targher G; Bellis A; Fornengo P; Ciaravella F; Pichiri I; Cavallo Perin P; Trimarco B; Marchesini G
    Dig Liver Dis; 2010 May; 42(5):331-40. PubMed ID: 20207207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.